Press release
Less than 2 weeks to go until the 13th annual ADMET event in London
Delegates will have the opportunity to network and hear insightful presentations and case studies on topics such as toxicology research strategies, modelling techniques, predictive pharmacology, pre-clinical DMPK studies, and many more.
Spotlight Presentations and Speakers:
“KPB – Strengths and limitations of compartmental modelling”, presented by Sheila-Annie Peters, Head, Translational Quantitative Pharmacology, Merck Serono. Peters will discuss the topics of the making of a successful drug candidate, as well as defining parameters in acute and chronic toxicity evaluations, drug safety testing, and cost-benefit assessments.
“Intracellular pharmacokinetics: Emerging opportunities for tailoring project support”, presented by Andreas Reichel, Vice President, Research Pharmacokinetics, Bayer. Reichel’s presentation will focus on the mechanisms that control intracellular drug concentrations, experimental approaches that are suitable to estimate unbound intracellular concentrations in selected cell types as well as their applicability to advance our understanding of intracellular drug-target interactions. In addition, sase studies will be shown to illustrate how the field of ICPK can offer novel opportunities that can be used to address key questions in drug discovery projects, thereby enhancing our understanding of the intracellular fate of drugs.
2018 Event Agenda:
Day 1: Opening keynote from AbbVie by Vice President, Global Pre-Clinical Safety, Senior Research Fellow, Eric Blomme on Novel technologies and computational tools in discovery toxicology: opportunities and challenges - his exclusive speaker Q&A interview is available on the event website’s download centre.
Day 2: Opening keynote from Vertex Pharmaceuticals by Peter Littlewood, Director of DMPK. The talk will discuss Human PK and dose predictions for compounds with challenging physiochemical profiles.
With the conference fast-approaching, places are now limited and potential attendees are urged to book soon at an exclusive price of £999 available for a limited time, to avoid disappointment. For the full agenda and list of expert speakers, download the latest brochure from the event website, as well as more exclusive free content including speaker interviews, at: www.admet-event.com/openpr
Interested in sponsoring, exhibiting or speaking at this event?
Contact Alia Malick, Director, on +44 (0) 20 827 6168 or email amalick@smi-online.co.uk
For media enquiries, contact Simi Sapal on +44 (0) 20 7827 6162 or ssapal@smi-online.co.uk
ADMET
9th – 10th July 2018
Holiday Inn Kensington Forum, London, UK
www.admet-event.com/openpr
Follow us @SMiPharm
#SMiADMET
About SMi Group: Established since 1993, the SMi Group is a global event-production company that specializes in Business-to-Business Conferences, Workshops, Masterclasses and online Communities. We create and deliver events in the Defence, Security, Energy, Utilities, Finance and Pharmaceutical industries. We pride ourselves on having access to the world’s most forward-thinking opinion leaders and visionaries, allowing us to bring our communities together to Learn, Engage, Share and Network. More information can be found at http://www.smi-online.co.uk
SMi Group Ltd
1 Westminster Bridge Rd, South Bank, London SE1 7XW
Simi Sapal
ssapal@smi-online.co.uk
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Less than 2 weeks to go until the 13th annual ADMET event in London here
News-ID: 1099881 • Views: …
More Releases from SMi Group
Exclusive Speaker Interview with AOBiome ahead of the 22nd Pain Therapeutics Con …
SMi Reports: Exclusive speaker interview with Todd Krueger at AOBiome released for the Pain Therapeutics Conference
The pain therapeutics industry has grown at an exponential rate in recent years. The 22nd Annual Pain Therapeutics conference will cover the leading advances in pain therapeutics, exploring late development clinical trials, novel treatments for chronic conditions, technology collaboration treatments, using VR and Medical Devices that carry out non-invasive nerve stimulation.
Industry leaders will uncover the…
Exclusive Speaker Interview with Ester Lovsin Barle ahead of the 6th Annual High …
Now in its 6th year, the Highly Potent Active Pharmaceutical Ingredients conference offers you peer-to-peer networking with industry experts including heads and directors of EHS, Occupational Hygiene, Quality Assurance and more. Taking place on 9th and 10th May in London, UK.
With a key focus on expanding your community and exploring the latest developments in the industry at this two-day event, including key regulatory updates, and leading case studies from leading…
FDA Keynote Speaker at SMi's 5th Annual Pharmaceutical Microbiology East Coast C …
SMi Group Reports: Keynote FDA speaker Dr. John Arigo, to present at the 4th Annual Pharmaceutical Microbiology East Coast, taking place in just 3 weeks' time on April 27th and 28th, 2022.
With just three weeks remaining until the highly anticipated conference, SMi Group are delighted to announce a key FDA Speaker joining the 5th Annual Pharmaceutical Microbiology East Coast Conference. This event will take place on April 27th and…
Group Captain (ret'd) Robert Daisley invites you to attend Air Mission Planning …
SMi Group reports: Chairman Group Captain (ret'd) Robert Daisley of the Air Mission Planning and Support Conference cordially invites experts to join the conference in London, UK in one week.
With only one week remaining, SMi Group is delighted to publish an invitation letter for SMi's 13th Annual Air Mission Planning & Support Conference, taking place on the 6th and 7th April 2022 in London, UK from the conference chairman.
The…
More Releases for ADMET
Evolving Market Trends In The Pharma ADMET Testing Industry: The Impact Of Produ …
The Pharma ADMET Testing Market Report by The Business Research Company delivers a detailed market assessment, covering size projections from 2025 to 2034. This report explores crucial market trends, major drivers and market segmentation by [key segment categories].
What Is the Expected Pharma ADMET Testing Market Size During the Forecast Period?
The market scale for pharma ADMET testing has seen substantial expansion in the past few years. The market, which is projected…
The Influence Of Increasing Product Approvals On The Pharma ADMET Testing Market …
What combination of drivers is leading to accelerated growth in the pharma admet testing market?
The pharma ADMET testing market is being propelled by an increasing count of product authorizations. These authorizations are described as the procedures through which bodies like the U.S. Food and Drug Administration or the European Medicines Agency give the green light for a product to be commercialized and available for the general public. The use of…
Pharma ADMET Testing Market Global Analysis & Forecast 2028
The Pharma ADMET Testing Market Research study to 2028 enhances the decision-making capabilities and helps to create potent counter strategies to obtain competitive advantage says a latest research report at The Insight Partners. The Pharma ADMET Testing Industry analysis is provided for the international markets including development trends, competitive landscape analysis, and key regions development status.
Market Players Density: Understanding Its Impact on Business Dynamics
The Pharma ADMET Testing Market market is…
Pharma ADMET Testing Market to Reach US$ 13,578.62 Million by 2028
The pharma ADMET testing market is expected to grow from US$ 6,783.06 million in 2021 to US$ 13,578.62 million by 2028; it is estimated to grow at a CAGR of 10.5% from 2022 to 2028.
An exclusive Pharma ADMET Testing Market research report has been fabricated through the in depth analysis of the market dynamics across five regions including North America, Europe, South America, Asia-Pacific, Middle East and Africa. The segmentation…
Wire Tension Tester Market | ABB, ADMET, Continental, GAP Group
The global wire tension tester market report is a comprehensive report that provides a detailed analysis of the current status and future trends of the wire tension tester market worldwide. This report provides valuable information to industry stakeholders by offering an in-depth perspective on market dynamics, competitive landscape, growth opportunities, and key challenges faced by industry participants.
From the perspective of market dynamics, this report explores the factors driving the growth…
Pharma ADMET Testing Market Comprehensive Analysis and Future Estimations by 202 …
The Pharma ADMET Testing Market is expected to grow from US$ 6,783.06 million in 2021 to US$ 13,578.62 million by 2028; it is estimated to grow at a CAGR of 10.5% from 2022 to 2028.
The report highlights trends prevailing in the market and factors driving the market growth. The market growth is attributed to the high rate of late-stage drug failure and the increasing number of products approvals and launches.…
